199 related articles for article (PubMed ID: 32645904)
1. Combination of Alanine and Glutathione as Targeting Ligands of Nanoparticles Enhances Cargo Delivery into the Cells of the Neurovascular Unit.
Porkoláb G; Mészáros M; Tóth A; Szecskó A; Harazin A; Szegletes Z; Ferenc G; Blastyák A; Mátés L; Rákhely G; Deli MA; Veszelka S
Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32645904
[TBL] [Abstract][Full Text] [Related]
2. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
3. A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model.
Veszelka S; Mészáros M; Porkoláb G; Szecskó A; Kondor N; Ferenc G; Polgár TF; Katona G; Kóta Z; Kelemen L; Páli T; Vigh JP; Walter FR; Bolognin S; Schwamborn JC; Jan JS; Deli MA
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056983
[TBL] [Abstract][Full Text] [Related]
4. Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.
Mészáros M; Phan THM; Vigh JP; Porkoláb G; Kocsis A; Páli EK; Polgár TF; Walter FR; Bolognin S; Schwamborn JC; Jan JS; Deli MA; Veszelka S
Cells; 2023 Feb; 12(3):. PubMed ID: 36766845
[TBL] [Abstract][Full Text] [Related]
5. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
6. ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood-Brain Barrier.
Topal GR; Mészáros M; Porkoláb G; Szecskó A; Polgár TF; Siklós L; Deli MA; Veszelka S; Bozkir A
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33383743
[TBL] [Abstract][Full Text] [Related]
7. Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells.
Veszelka S; Meszaros M; Kiss L; Kota Z; Pali T; Hoyk Z; Bozso Z; Fulop L; Toth A; Rakhely G; Deli MA
Curr Pharm Des; 2017; 23(28):4198-4205. PubMed ID: 28748755
[TBL] [Abstract][Full Text] [Related]
8. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.
Moura RP; Almeida A; Sarmento B
Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762
[TBL] [Abstract][Full Text] [Related]
9. Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands.
Moreira R; Nóbrega C; de Almeida LP; Mendonça L
J Nanobiotechnology; 2024 May; 22(1):260. PubMed ID: 38760847
[TBL] [Abstract][Full Text] [Related]
10. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
11. Modeling the blood-brain barrier: Beyond the endothelial cells.
Gastfriend BD; Palecek SP; Shusta EV
Curr Opin Biomed Eng; 2018 Mar; 5():6-12. PubMed ID: 29915815
[TBL] [Abstract][Full Text] [Related]
12. Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro.
Zozulya A; Weidenfeller C; Galla HJ
Brain Res; 2008 Jan; 1189():1-11. PubMed ID: 18061148
[TBL] [Abstract][Full Text] [Related]
13. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.
Moura RP; Martins C; Pinto S; Sousa F; Sarmento B
Expert Opin Drug Deliv; 2019 Mar; 16(3):271-285. PubMed ID: 30767695
[TBL] [Abstract][Full Text] [Related]
15. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
16. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
[TBL] [Abstract][Full Text] [Related]
17. An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.
Canfield SG; Stebbins MJ; Morales BS; Asai SW; Vatine GD; Svendsen CN; Palecek SP; Shusta EV
J Neurochem; 2017 Mar; 140(6):874-888. PubMed ID: 27935037
[TBL] [Abstract][Full Text] [Related]
18. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
19. Transport of drugs across the blood-brain barrier by nanoparticles.
Wohlfart S; Gelperina S; Kreuter J
J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
[TBL] [Abstract][Full Text] [Related]
20. Shuttle-mediated nanoparticle transport across an in vitro brain endothelium under flow conditions.
Falanga AP; Pitingolo G; Celentano M; Cosentino A; Melone P; Vecchione R; Guarnieri D; Netti PA
Biotechnol Bioeng; 2017 May; 114(5):1087-1095. PubMed ID: 27861732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
